TRIAL TO ASSESS THE INFLUENCE OF 4 WEEKS' TREATMENT WITH LINAGLIPTIN AS COMPARED TO GLIMEPIRIDE AND PLACEBO ON ENDOTHELIAL FUNCTION IN PATIENTS WITH TYPE 2 DIABETES USING FMD (FLOW-MEDIATED VASODILATION):